Market Revenue DNA Vaccines Industry Regional Movement Analysis | Page 2

The key driving factors responsible for the growth of DNA vaccines market include growing vulnerability of
population to infectious disease and rising number of antibiotics resistant pathogens have generated the need
for effective and low cost vaccination which would provide lasting immunity. On the basis of disease type, the
global DNA vaccines market is segmented into human DNA vaccines and animal DNA vaccines. Human DNA
vaccines market is further segmented into HIV infection, cancer and infectious diseases.
On the basis of technology, the global DNA vaccines market is segmented into pDNA vaccines technology and
pDNA delivery technology. pDNA vaccines technology is further sub-segmented into therapeutic technology and
preventive technology. pDNA delivery technology is further sub-segmented into uncomplexed pDNA,
liposomes, gold particles, electroporation, bacteriophages, bacterial ghosts, nanoparticles and viruses.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/dna-vaccines-market
On the basis of application, the global DNA vaccines market is segmented into human diseases, and veterinary
diseases. Human diseases are further sub-segmented into oncology, allergies and infectious diseases. Oncology
is further sub-segmented into pancreatic cancer, breast cancer, ovarian cancer, small cell lung cancer and
melanoma. Infectious disease is further segmented into CMV, HBV, HCV, HIV and Influenza.
Veterinary disease is further sub-segmented into canine melanoma, leishmaniosis, and Equine West NileVirus.
The key players in the global DNA vaccines market spans Novartis Animal Health, Inovio Biomedical Corp, Merck
& Co, Dendreon Corporation, Pfizer pharmaceuticals, GlaxoSmithKline, Advance Bioscience Laboratories Inc,
Indian Immunologicals Ltd, Xenetic Biosciences Inc, QED Biosciences Inc, Astellas Pharma, Vical, Sanofi and
Tekmira Pharmaceuticals.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/pharmaceuticals